Publications
- Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis2021 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?2017 | First Faculty of Medicine
- Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later2016 | First Faculty of Medicine
- Early magnetic resonance imaging predictors of clinical progression after 48months in clinically isolated syndrome patients treated with intramuscular interferon beta-1a2015 | First Faculty of Medicine
- Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome2015 | First Faculty of Medicine
- MRI correlates of disability progression in patients with CIS over 48 months2014 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment2014 | First Faculty of Medicine
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Current and future therapeutic options for the treatment of the generalized form of myasthenia gravis2023 | First Faculty of Medicine
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
Loading network view...